International Stem Cell Corp. (OTCMKTS:ISCO – Get Free Report)’s stock price passed above its two hundred day moving average during trading on Thursday. The stock has a two hundred day moving average of $0.24 and traded as high as $0.33. International Stem Cell shares last traded at $0.3041, with a volume of 9,151 shares trading hands.
International Stem Cell Stock Performance
The stock’s 50-day simple moving average is $0.36 and its two-hundred day simple moving average is $0.24. The stock has a market cap of $2.32 million, a price-to-earnings ratio of -3.62 and a beta of -0.05.
International Stem Cell (OTCMKTS:ISCO – Get Free Report) last announced its earnings results on Thursday, August 13th. The biotechnology company reported ($0.01) earnings per share for the quarter. The company had revenue of $2.67 million during the quarter.
About International Stem Cell
International Stem Cell Corporation is a biotechnology company focused on developing human stem cell-based products and therapies. Its research has centered on proprietary parthenogenetic human stem cells, which are derived from unfertilized human oocytes and are intended to provide a potentially useful source of cells for regenerative medicine.
The company has pursued applications in tissue engineering and cell therapy, including programs involving corneal tissue and other specialized cell types.
Featured Articles
- Five stocks we like better than International Stem Cell
- 3 AI Winners, 3 Very Different Paths to Higher Margins
- Plexus Is Booming—But Can the Growth Story Last?
- Conagra’s Turnaround Is Starting to Show Up in the Numbers
- MarketBeat Week in Review – 09/28 – 10/02
Receive News & Ratings for International Stem Cell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Stem Cell and related companies with MarketBeat.com's FREE daily email newsletter.
